Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Retinoblastoma_Awareness_Month
|
| gptkbp:affects |
retina
|
| gptkbp:can_lead_to |
psychosocial challenges
educational support needs |
| gptkbp:can_metastasize_to |
gptkb:healthcare_organization
gptkb:skincare_product lymph nodes |
| gptkbp:caused_by |
vision loss
eye removal death if untreated |
| gptkbp:current_use |
strabismus
leukocoria |
| gptkbp:disease_resistance |
gptkb:20th_century
|
| gptkbp:end_of_life |
around 70% for advanced cases
over 95% for localized cases |
| gptkbp:events |
necessary after treatment
|
| gptkbp:first_described_by |
1890s
Hugh A. Mc Cullough |
| gptkbp:genetic_diversity |
R B1 gene
|
| gptkbp:historical_event |
radiation therapy
|
| https://www.w3.org/2000/01/rdf-schema#label |
Retinoblastoma
|
| gptkbp:is_linked_to |
other cancers in survivors
|
| gptkbp:is_monitored_by |
regular check-ups
|
| gptkbp:is_often_gifted |
asymptomatic findings
|
| gptkbp:is_often_used_in |
gptkb:Person
developing countries |
| gptkbp:is_popular_in |
1 in 15,000 births
|
| gptkbp:premiered_on |
infancy
|
| gptkbp:requires |
prolonged treatment
|
| gptkbp:research_focus |
early detection
treatment advancements |
| gptkbp:risk_factor |
family history
genetic predisposition |
| gptkbp:scientific_classification |
primary intraocular tumor
|
| gptkbp:screenings |
regular eye exams
|
| gptkbp:social_responsibility |
biopsy
imaging tests eye examination depends on stage |
| gptkbp:symptoms |
vision problems
crossed eyes white pupil |
| gptkbp:treatment |
gptkb:hospital
clinical trials radiation therapy chemotherapy oncologists prevent metastasis enucleation preserve vision |
| gptkbp:type |
hereditary
non-hereditary |